Business Services
Cancer Prevention
Medical

Celcuity

$23.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (1.01%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Celcuity and other stocks, options, ETFs, and crypto commission-free!

About CELC

Celcuity Inc. Common Stock, also called Celcuity, is cellular analysis company. Read More The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.

Employees
26
Headquarters
Minneapolis, Minnesota
Founded
2012
Market Cap
233.48M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
5.12K
High Today
$23.30
Low Today
$22.54
Open Price
$23.04
Volume
5.98K
52 Week High
$31.00
52 Week Low
$18.31

Collections

Business Services
Cancer Prevention
Medical
Technology
Therapy
Health
2017 IPO
US

CELC Earnings

-$0.25
-$0.21
-$0.18
-$0.14
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.